Abstract
Best vitelliform macular dystrophy (Best VMD) also called Best disease is a clinically heterogeneous and pleomorphic disease, in most cases showing an autosomal dominant pattern of inheritance with extremely variable penetrance and expressivity. In most cases, patients harbour heterozygous mutation in BEST1 gene, coding for a protein acting as a Ca2+-activated Cl− channel. In most cases the disease begins in the first decade of life. Five stages based on fundus examination have been described: each stage is also characterized by typical spectral-domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) signs. BEST1 gene is also related to other diseases, called bestrophinopathies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Best F. Uber eine hereditare maculaafektion; Beitrage zur verergslehre. Zschr Augenheilkd. 1905;13:199–212.
Stone EM, Nichols BE, Streb LM, Kimura AE, Sheffield VC. Genetic linkage of vitelliform macular degeneration (Best’s disease) to chromosome 11q13. Nat Genet. 1992;1(4):246–50.
Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19(3):241–7.
Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A. 2002;99:4008–13.
Boon CJ, Klevering BJ, Leroy BP, Hoyng CB, Keunen JE, den Hollander AI. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28(3):187–205.
Kaufman SJ, Goldberg MF, Orth DH, Fishman GA, Tessler H, Mizuno K. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100:272–8.
Lotery AJ, Munier FL, Fishman GA, Weleber RG, Jacobson SG, Affatigato LM, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41(6):1291–6.
Bakall B, Radu RA, Stanton JB, Burke JM, McKay BS, Wadelius C, et al. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res. 2007;85(1):34–43.
Gass JD. A clinicopathologic study of a peculiar foveomacular dystrophy. Trans Am Ophthalmol Soc. 1974;72:139–56.
Patrinely JR, Lewis RA, Font RL. Foveomacular vitelliform dystrophy, adult type: a clinicopathologic study including electron microscopic observations. Ophthalmology. 1985;92:1712–8.
Davidson AE, Millar ID, Urquhart JE, Burgess-Mullan R, Shweikh Y, Parry N, et al. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet. 2009;85(5):581–92.
Burgess R, Millar ID, Leroy BP, Urquhart JE, Fearon IM, De Baere E, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82(1):19–31.
Manes G, Meunier I, Avila-Fernndez A, Banfi S, Le Meur G, Zanlonghi X, et al. Mutations in IMPG1 cause vitelliform macular dystrophies. Am J Hum Genet. 2013;93(3):571–8.
Nordstrom S, Barkman Y. Hereditary macular degeneration (HMD) in 246 cases traced to one gene-source in central Sweden. Hereditas. 1977;84:163–76.
Deutman AF, Hoyng CB. Macular dystrophies. In: Ryan SJ, editor. Retina. 3rd ed. St. Louis: Mosby; 2001. p. 1210–57.
Thorburn W, Nordström S. EOG in a large family with hereditary macular degeneration. (Best’s vitelliform macular dystrophy) identification of gene carriers. Acta Ophthalmol (Copenh). 1978;56(3):455–64.
Marmor MF. “Vitelliform” lesions in adults. Ann Ophthalmol. 1979;11(11):1705–12.
Querques G, Zerbib J, Georges A, Massamba N, Forte R, Querques L, et al. Multimodal analysis of the progression of Best vitelliform macular dystrophy. Mol Vis. 2014;20:575–92.
Mohler CW, Fine SL. Long-term evaluation of patients with Best’s vitelliform dystrophy. Ophthalmology. 1981;88:688–92.
Querques G, Regenbogen M, Quijano C, Delphin N, Soubrane G, Souied EH. High definition optical coherence tomography features in vitelliform macular dystrophy. Am J Ophthalmol. 2008;146:501–7.
Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31(8):1609–19.
Querques G, Zerbib J, Santacroce R, Margaglione M, Delphin N, Querques L, et al. The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. Invest Ophthalmol Vis Sci. 2011;52(7):4678–84.
Querques G, Zerbib J, Santacroce R, Margaglione M, Delphin N, Rozet JM, et al. Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis. 2009;15:2960–72.
Querques G, Regenbogen M, Soubrane G, Souied EH. High-resolution spectral domain optical coherence tomography findings in multifocal vitelliform macular dystrophy. Surv Ophthalmol. 2009;54(2):311–6.
Arnold JJ, Sarks JP, Killingsworth MC, Kettle EK, Sarks SH. Adult vitelliform macular degeneration: a clinicopathological study. Eye (Lond). 2003;17(6):717–26.
Maruko I, Iida T, Spaide RF, Kishi S. Indocyanine green angiography abnormality of the periphery in vitelliform macular dystrophy. Am J Ophthalmol. 2006;141(5):976–8.
Deutman AF. Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state. Arch Ophthalmol. 1969;81(3):305–16.
Meunier I, Sénéchal A, Dhaenens CM, Arndt C, Puech B, Defoort-Dhellemmes S, et al. Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis. Ophthalmology. 2011;118(6):1130–6.
Blodi CF, Stone EM. Best’s vitelliform dystrophy. Ophthalmic Paediatr Genet. 1990;11(1):49–59.
Cross HE, Bard L. Electro-oculography in Best’s macular dystrophy. Am J Ophthalmol. 1974;77(1):46–50.
Caldwell GM, Kakuk LE, Griesinger IB, Simpson SA, Nowak NJ, Small KW, et al. Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. Genomics. 1999;58(1):98–101.
Wabbels B, Preising MN, Kretschmann U, Demmler A, Lorenz B. Genotype-phenotype correlation and longitudinal course in ten families with best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2006;244(11):1453–66.
Fishman GA, Baca W, Alexander KR, Derlacki DJ, Glenn AM, Viana M. Visual acuity in patients with best vitelliform macular dystrophy. Ophthalmology. 1993;100(11):1665–70.
Booij JC, Boon CJ, van Schooneveld MJ, ten Brink JB, Bakker A, de Jong PT, et al. Course of visual decline in relation to the BEST1 genotype in vitelliform macular dystrophy. Ophthalmology. 2010;117(7):1415–22.
Leu J, Schrage NF, Degenring RF. Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2007;245(11):1723–5.
Querques G, Bocco MC, Soubrane G, Souied EH. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy. Acta Ophthalmol. 2008;86(6):694–5.
Boon CJ, Theelen T, Hoefsloot EH, van Schooneveld MJ, Keunen JE, Cremers FP, et al. Clinical and molecular genetic analysis of best vitelliform macular dystrophy. Retina. 2009;29(6):835–47.
Burgess DB, Olk RJ, Uniat LM. Macular disease resembling adult foveomacular vitelliform dystrophy in older adults. Ophthalmology. 1987;94(4):362–6.
Boon CJ, Klevering BJ, Hoyng CB, Zonneveld-Vrieling MN, Nabuurs SB, Blokland E, et al. Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am J Hum Genet. 2008;82(2):516–23.
Gass JD, Chuang EL, Granek H. Acute exudative polymorphous vitelliform maculopathy. Trans Am Ophthalmol Soc. 1988;86:354–66.
Eksandh L, Adamus G, Mosgrove L, Andréasson S. Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma. Arch Ophthalmol. 2008;126(3):432–5.
Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45(10):3683–9.
Burgess R, MacLaren RE, Davidson AE, Urquhart JE, Holder GE, Robson AG, et al. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet. 2009;46(9):620–5.
Reddy MA, Francis PJ, Berry V, Bradshaw K, Patel RJ, Maher ER, Kumar R, Bhattacharya SS, Moore AT. A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, rod-cone dystrophy, cataract, and posterior staphyloma. Br J Ophthalmol. 2003;87(2):197–202.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zerbib, J., Souied, E.H., Querques, G. (2016). Best Vitelliform Macular Dystrophy. In: Querques, G., Souied, E. (eds) Macular Dystrophies. Springer, Cham. https://doi.org/10.1007/978-3-319-26621-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-26621-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26619-0
Online ISBN: 978-3-319-26621-3
eBook Packages: MedicineMedicine (R0)